Due to COVID-19, the ASAM Treatment of OUD Courses on April 23 and May 12 will be rescheduled. Please check this page for updates.

Additional Trainings


ASAM Treatment of Opioid Use Disorder Course on April 23 and May 12

Women's health providers can now register for the ASAM Treatment of Opioid Use Disorder Course, which is being held in two locations across Pennsylvania:


Register here for Western PA: Thursday, April 23 from 8:00 a.m. to 1:00 p.m. at the Magee-Womens Research Institute (MWRI) (204 Craft Ave, Pittsburgh, PA 15213)


Register here for Eastern PA: Tuesday, May 12 from 8:00 a.m. to 1:00 p.m. at the DoubleTree by Hilton Hotel Philadelphia Center City (237 S Broad St, Philadelphia, PA 19107)

This course is being hosted by ASAM, ACOG, and the PA PQC. It covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. This is an 8-hour blended course combining 4 hours of online learning followed by 4 hours of live learning. The live portion of the course builds off content delivered in the online portion. Course faculty are expecting learners to complete the online portion before attending the live portion. Participants must complete both portions to receive credit for the course. Please click the registration links above for more information, including information about CMEs and how to apply for the waiver.

Participants are required to pay $25.00 to register for the course. The intended audience for the course includes physicians, nurse practitioners, clinical nurse specialists, and physician assistants who wish to obtain a waiver to prescribe buprenorphine in office-based treatment of opioid use disorder. The course is also designed for clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder. The curriculum for this course has been specifically designed for women's health providers (please see below for the learning objectives).

Learning Objectives

  • Identify the importance of screening for substance use disorders
  • Describe the mechanism of opioid withdrawal
  • Discuss options to treat opioid withdrawal
  • Explain the safety and efficacy of buprenorphine to treat opioid use disorder
  • Explain the safety of medications in antepartum, postpartum, and breastfeeding period
  • Describe how to start a patient (induction) on buprenorphine in an office-based setting
  • Discuss successful non-pharmacological ways to treat Neonatal Abstinence Syndrome

Training on SAMHSA’s Clinical Guidance for Treating Pregnant and Parenting Women with OUD and Their Infants on May 20

The Pennsylvania Department of Health is hosting a training on SAMHSA’s “Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants” on May 20 from 8:00 a.m. to 4:00 p.m. at the Pennsylvania Child Welfare Resource Center (403 E Winding Hill Rd, Mechanicsburg, PA). It is provided at no cost and includes lunch, CME/CEs, and a copy of SAMHSA’s clinical guidance book.
Due to overwhelming interest, this training is now full. If you would like to be added to the waitlist in case seats open up or to be notified of potential future training dates, please use the waitlist function in the course registration.

To be added to the Waitlist:

  1. Login to your existing account in TRAIN or create an account
    1. On the home page of the TRAIN PA site, there is an option to create an account under the login section: https://www.train.org/pa/welcome
  2. Once logged in, go to the course registration page: https://www.train.org/pa/admin/course/1088856/live_event?idU=1&utm_source=newsletter_159&utm_medium=email&utm_campaign=training-on-treating-pregnant-women-with-oud-and-their-infants-may-20
  3. Click “Add to Wait List” (see screen shot below)
  4. Select continuing education credit type or None
  5. Click “Ok”
  6. waiting list 

     

     

     

    pregnant and parenting